Semaglutide in people with HIV-associated lipohypertrophy
- PMID: 38964354
- DOI: 10.1016/S2213-8587(24)00162-1
Semaglutide in people with HIV-associated lipohypertrophy
Conflict of interest statement
We declare no competing interests.
Comment on
-
Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial.Lancet Diabetes Endocrinol. 2024 Aug;12(8):523-534. doi: 10.1016/S2213-8587(24)00150-5. Epub 2024 Jul 1. Lancet Diabetes Endocrinol. 2024. PMID: 38964353 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
